Rankings
▼
Calendar
MIRM FY 2021 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
MIRM
Mirum Pharmaceuticals, Inc.
$5B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$19M
Gross Profit
$17M
90.1% margin
Operating Income
-$173M
-906.1% margin
Net Income
-$84M
-438.9% margin
EPS (Diluted)
$-2.77
Cash Flow
Operating Cash Flow
-$133M
Free Cash Flow
-$152M
Stock-Based Comp.
$23M
Balance Sheet
Total Assets
$295M
Total Liabilities
$174M
Stockholders' Equity
$120M
Cash & Equivalents
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$19M
$0
—
Gross Profit
$17M
-$623,000
+2866.5%
Operating Income
-$173M
-$104M
-66.3%
Net Income
-$84M
-$103M
+18.7%
← Q4 2020
All Quarters
Q1 2021 →